Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SPL84 in cystic fibrosis is currently recruiting to assess safety, tolerability, pharmacokinetics, and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• SPL84

Snippet

Sponsor: SpliSense Ltd. | Conditions: Cystic Fibrosis | Phase 2 | Status: RECRUITING